STUDY ON PREVALENCE OF ASSOCIATION BETWEEN METABOLIC SYNDROME COMPONENTS

Authors

  • Elena POPA “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Mihaela BOANCA “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • V. POROCH “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Agnes Iacinta BACUSCA “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Ana Maria SLANINA “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Monica UNGUREANU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Gema BACOANU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Adorata Elena COMAN “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

In Europe, approximately 25% of population are estimated to have metabolic syndrome (MS), with similar prevalence values in Latin America. In general, the prevalence of the metabolic syndrome increases with age with nearly 40% of people aged 60 and older meeting the diagnostic criteria. Material and methods: The purpose of this study is to evaluate the prevalence of associations between metabolic syndrome components to find a pattern applicable to patients with this pathology. The study was conducted on a total of 1,528 patients over 18 months, from 01.06.2017 to 31.12.2018, within a general practitioner (GP) medical office, being an epidemiological case-control study. Results: Studying the distribution of Harmonized I  diagnostic criteria in the research group, we obtained the following data: 15.7% of subjects were included into MS with three components (MS3); 6.9% of the participants fall into the MS with four components (MS4); 2.87% of the patients included in the study group all five components of the metabolic syndrome (MS5). Out of a total of 203 women diagnosed with MS, we identified the presence of five-component MS in 10.83% of MS patients, while 31.03% were diagnosed with MS4. Conclusions: Early diagnosis of MS by the family doctor may reduce the cardiometabolic risk, the costs it generates, and could increases patients’ quality of life.

Author Biographies

  • Elena POPA, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Preventive Medicine and Interdisciplinarity

  • V. POROCH, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Medical Specialties (II)
    Regional Institute of Oncology Iasi,
    Palliative Care Department

  • Agnes Iacinta BACUSCA, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Preventive Medicine and Interdisciplinarity

  • Ana Maria SLANINA, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Preventive Medicine and Interdisciplinarity

  • Monica UNGUREANU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Preventive Medicine and Interdisciplinarity

  • Gema BACOANU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Ph.D. Student

  • Adorata Elena COMAN, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Preventive Medicine and Interdisciplinarity

References

1. Diaa A, Popa E, Bacusca A, Traian MG, Petrovanu R, Coman AE. Epidemiological study of metabolic syndrome and risk of diabetes mellitus in a rural family medicine practice in Bacau County. Rev Med Chir Soc Med Nat Iasi 2014; 118 (3): 772-779.
2. Coman A, Petrovanu R. Sindromul metabolic in practica de ambulator. Iasi, Romania: Editura Pim, 2009.
3. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008; 28(4): 629-636.
4. Costache II, Ungureanu MC, Iliescu D, et al. Electrocardiographic changes in the most frequent endocrine disorders associated with cardiovascular diseases. Review of the literature. Rev Med Chir Soc Med Nat Iasi 2015; 119(1): 18-22.
5. Mulè G, Calcaterra I, Nardi E, Cerasola G, Cottone S. Metabolic syndrome in hypertensive patients: An unholy alliance. World J Cardiol 2014; 6(9): 890-907.
6. DeBoer MD, Gurka MJ. Clinical utility of metabolic syndrome severity scores: considerations for practitioners. Diabetes Metab Syndr Obes 2017; 10: 65-72.
7. Hanefeld M, Pistrosch F, Bornstein S, Birkenfeld A. The metabolic vascular syndrome - guide to an individualized treatment. Rev Endocr Metab Dis 2016; 17: 5-17.
8. Matei C, Pop I, Jurcut R, et al. Romanian multicentric study of the prevalence of metabolic syndrome - ROMES. Hellenic J Cardiol 2008; 49(5): 303-309.
9. Botnariu G, Forna N, Popa A, et al. Correlation of Glycemic Control Parameters in Non-Diabetic Persons with Cardiovascular Risk Scores-Results from a Cross-Sectional Study. Revista de Chimie 2017; 68(1): 108-110.
10. Dorobantu M, Darabont R, Ghiorghe S, Arsenescu-Georgescu C. Hypertension prevalence and control in Romania at a seven-year interval. Comparison of SEPHAR I and II surveys. J Hipertens 2014; 32(1): 39-47.
11. Ganceanu-Rusu R, Mititelu-Tartau L, Statescu C, Boanca M, Lupusoru RV, Dima N, Rezus E, Rezus C, Lupusoru CE. Evolution of biological parameters in the metabolic syndrome. Rev Med Chir Soc Med Nat Iasi 2017; 121(3): 638-644.
12. Popa E, Zugun-Eloae F, Zlei M, et al. Flow Cytometry Analysis of Pparα Receptors in Metabolic Syndrome RRLM 2014; 22 (4): 427-438.
13. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep 2018; 20: 12.
14. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. American Heart Association National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute / American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438
15. Van Ancum JM, Jonkman NH, van Schoor NM, et al. Predictors of Metabolic Syndrome in Commu-nity-Dwelling Older Adults. PLoS One 2018; 13(10): e0206424.
16. Bassi N, Karagodin I, Wang S, et al. Lifestyle Modification for Metabolic Syndrome: A Systematic Review AJM 2014; 127(12): P1242.E1-1242.E10.

Additional Files

Published

2020-06-30

Issue

Section

INTERNAL MEDICINE - PEDIATRICS